Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.4347 (USD) • At close October 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 3.93-20.963-7.798-4.333-3.838-14.575-5.328-5.557-3.636-3.537-2.752-5.201-1.1-0.964-0.88-0.702-0.338-0.344-0.702-0.564-0.45-0.45
Depreciation & Amortization -0.1130.2840.0820.0790.0780.0450.0420.040.040.0390.00100000000000
Deferred Income Tax 00-0.28700001.647-0.4060000000000000
Stock Based Compensation 0.6410.5220.550.9290.1440.1440.1970.2660.2940.290.2310.2390.2940.2020.0710.070.060.0310.024000
Change In Working Capital 0.1081.8931.1210.299-1.6040.091-1.0161.6880.2550.2511.208-1.2790.148-0.1820.032-0.282-0.0190.103-0.0150.115-0.052-0.052
Accounts Receivables 000000000000-0.028-0.0100000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables -0.3720.8220.4271.484-0.442-0.193-0.6411.954-0.070.0240.7780.4430.103-0.0830.02-0.2-0.0160.1280000
Other Working Capital 0.481.0710.694-1.185-1.1620.193-0.375-0.2660.3250.2270.43-1.7220.045-0.0990.012-0.082-0.003-0.025-0.0150.115-0.052-0.052
Other Non Cash Items -9.98512.0761.893-1.396-0.28210.3750.021-1.6470.4060.307-0.0912.7670.4410.2710.2390.2080.1550.1370.2440.3470.1890.189
Operating Cash Flow -6.319-6.456-4.439-4.422-5.502-3.92-6.084-3.563-3.047-2.957-1.403-3.474-0.217-0.673-0.538-0.706-0.142-0.073-0.449-0.102-0.313-0.313
Investing Activities:
Investments In Property Plant And Equipment -0.02-0.00600-0.0120-0.00200-0.002-0.02900000000000
Acquisitions Net 0000000000000000000000
Purchases Of Investments 0000000000000000000000
Sales Maturities Of Investments 0000000000000000000000
Other Investing Activites 0000000000000000000000
Investing Cash Flow -0.02-0.00600-0.0120-0.00200-0.002-0.02900000000000
Financing Activities:
Debt Repayment 0000000000-1.361-0.89-0.174-0.701-0.01-0.15000000
Common Stock Issued 046.18732.3430028.0370.011000-20.0822.27100.119-0.00100.0920.050000
Common Stock Repurchased 13,088.4270-11,655.92510,321.6160000000000-0.0010000000
Dividends Paid -1.095-0.208-0.86700-0.1920000000000000000
Other Financing Activities 0.284-0.496-0.205-0.051027.797-0.48200018.71921.4840.0710.820.4860.9180.0490.010.4630.1020.3010.301
Financing Cash Flow -0.81145.691-0.205-0.051027.797-0.471000021.4840.0710.820.4750.7680.1410.060.4630.1020.3010.301
Other Information:
Effect Of Forex Changes On Cash 00-5.51405.51400.0020001.36100000000000
Net Change In Cash -7.1539.229-4.644-4.473-5.51423.877-6.555-3.563-3.047-2.959-1.43218.01-0.1460.147-0.0630.062-0.001-0.0130.0140-0.012-0.012
Cash At End Of Period 41.7848.939.70114.34518.81824.3320.4557.0110.57313.6216.57918.0110.0010.14700.0630.0010.0020.0150.0010.001-0.012